Activated protein C attenuates acute lung injury and apoptosis in a hyperoxic animal model

Shock

Volumn 33, Issue 5, 2010, Pages 467-472

  Husari, Ahmad W ^a   Khayat, Aline ^a   Awdeh, Haitham ^a   Hatoum, Hadi ^a   Nasser, Michel ^b   Mroueh, Salman M ^b   Zaatari, Ghazi ^c   El Sabban, Marwan ^b   Dbaibo, Ghassan S ^b,d  

^a Division of Pulmonary and Critical Care Medicine   (United States)

^b Department of Physiology ^*  (United States)

^c Department of Pathology Laboratory Medicine   (United States)

^d AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Anticoagulant; Inflammatory mediators; Oxygen; Pathology; Pulmonary system

Indexed keywords

ACTIVATED PROTEIN C; ALBUMIN; DROTRECOGIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; PROTEIN C;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ATTENUATION; CONTROLLED STUDY; DRY DEPOSITION; GENE EXPRESSION; HISTOPATHOLOGY; HYPEROXIA; IMMUNE RESPONSE; INJECTION; LUNG; LUNG EDEMA; MALE; MEDIATOR; NEUTROPHIL; NICK END LABELING; NONHUMAN; PNEUMONIA; RAT; TRANSCRIPTION INITIATION; WET DEPOSITION; ANIMAL; DRUG EFFECTS; ENZYME ACTIVATION; INFLAMMATION; METABOLISM; MORTALITY; PATHOLOGY;

ACUTE LUNG INJURY; ANIMALS; APOPTOSIS; ENZYME ACTIVATION; HYPEROXIA; IN SITU NICK-END LABELING; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; PROTEIN C; RATS;

EID: 77951454999     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181c69213     Document Type: Article

References (31)

1. Hasegawa N, Husari AW, Hart WT, Kandra TG, Raffin TA: Role of the coagulation system in ARDS. Chest 105:268-277, 1994. (Pubitemid 24029116)
2. Chambers RC: Procoagulant signaling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention? Br J Pharmacol 153:S367YS378, 2008.
3. Ware LB, Camerer E, Welty-Wolf K, Schultz MJ, Matthay MA: Bench to bedside: targeting coagulation and fibrinolysis in acute lung injury. Am J Physiol Lung Cell Mol Physiol 291:L307YL311, 2006. (Pubitemid 44343703)
4. Dhainaut JF, Yan SB, Claessens YE: Protein C/activated protein C pathway: overview of clinical trial results in severe sepsis. Crit Care Med 32:S194YS201, 2004.
5. Zeerleder S, Hack CE, Wuillemin WA: Disseminated intravascular coagulation in sepsis. Chest 128:2864-2875, 2005. (Pubitemid 41507648)
6. Dhainaut J-F, Laterre P-F, LaRosa SP, Levy H, Garber GE, Heiselman D, Kinasewitz GT, Light RB, Morris P, Schein R, et al.: The clinical evaluation committee in a large multicenter phase 3 trial of DrotAA in patients with severe sepsis (PROWESS): role, methodology, and results. Crit Care Med 31: 2291-2301, 2003. (Pubitemid 37100831)
7. Nick JA, Coldren CD, Geraci MW, Poch KR, Fouty BW, O'Brien J, Gruber M, Zarini S, Murphy RC, Kuhn K: Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis. Blood 104:3878-3885, 2004. (Pubitemid 39620133)
8. Murakami K, Okajima K, Uchiba M, Johno M, Nakagaki T, OkabeA H, Takatsuki K: ctivated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats. Blood 87:642-647, 1996. (Pubitemid 26030319)
9. Jian MY, Koizumi T, Tsushima K, Fujimoto K, Kubo K: Activated protein C attenuates acid-aspiration lung injury in rats. Pulm Pharmacol Ther 18: 291-296, 2005. (Pubitemid 40379752)
10. Yamenel L, Mas MR, Comert B, Isik AT, Aydin S, Mas N, Deveci S, Ozyurt M, Tasci I, Unal T: The effect of activated protein C on experimental acute necrotizing pancreatitis. Crit Care 9:R184YR190, 2005.
11. Teke Z, Sacar M, Yenisey C, Atalay AO, Bicakci T, Erdem E: Activated protein C attenuates intestinal reperfusion-induced acute lung injury: an experimental study in a rat model. Am J Surg 195:861-873, 2008. (Pubitemid 351749444)
12. HjYesilirmak DC, Kumral A, Tugyan K, Cilaker S, Baskin H, Yilmaz O, Duman N, Ozkan H: Effects of activated protein C on neonatal hypoxic is-chemic brain injury. Brain Res 1210:56-62, 2008.
13. Wong SS, Sun NN, Hyde JD, Ruiz L, Meigs E, Herrin BR, Fastje CD, Macdonald SJ, Witten ML: Drotrecogin alfa (activated) prevents smoke-induced increases in pulmonary microvascular permeability and proinflamma-tory cytokine IL-1beta in rats. Lung 182:319-330, 2004. (Pubitemid 40685143)
14. Chen LW, Hwang YC, Wang JS, Chen JS, Hsu CM: Inhibition of nitric oxide synthase reverses the effect of albumin on lung damage in burn. J Am Coll Surg 200:574-583, 2005.
15. Peinnequin A, Mouret C, Birot O, Alonso A, Mathieu J, Clarençon D, Agay D, Chancerelle Y, Multon E: A Rat pro-inflammatory cytokine and cytokine related mRNA quantification by real-time polymerase chain reaction using SYBR green. BMC Immunol 5:3, 2004. (Pubitemid 38692940)
16. Li LF, Liao SK, Ko YS, Lee CH, Quinn DA: Hyperoxia increases ventilator-induced lung injury via mitogen-activated protein kinases: a prospective, controlled animal experiment. Crit Care 11:R25, 2004.
17. Husari AW, Dbaibo GS, Bitar H, Khayat A, Panjarian S, Nasser M, Bitar FF, El-Sabban M, Zaatari G, Mroueh SM: Apoptosis and the activity of ceramide, Bax and Bcl-2 in the lungs of neonatal rats exposed to limited and prolonged hyperoxia. Respir Res 7:100, 2006.
18. Barazzone C, White CW: Mechanisms of cell injury and death in hyperoxia: role of cytokines and Bcl-2 family proteins. Am J Respir Cell Mol Biol 22: 517-519, 2000. (Pubitemid 30319535)
19. Mukhopadhyay S, Hoidal JR, Mukherjee TK: Role of TNF alpha in pulmonary pathophysiology. Respir Res 7:125, 2006. (Pubitemid 44637860)
20. Agouridakis P, Kyriakou D, Alexandrakis MG, Agouridakis P, Prekates A, Perisinakis K, Karkavitsas N, Bouros D: The predictive role of serum and bronchoalveolar lavage cytokines and adhesion molecules for acute respiratory distress syndrome development and outcome. Respir Res 3:25, 2002. (Pubitemid 41358111)
21. Guthmann F, Wissel H, Schachtrup C, Tölle A, Rüdiger M, Spener F, Rüstow B: Inhibition of TNF alpha in vivo prevents hyperoxia-mediated activation of caspase 3 in type II cells. Respir Res 6:10, 2005. (Pubitemid 41358058)
22. Dinarello CA: Biologic basis for interleukin-1 in disease. Blood 87:2095-2147, 1996.
23. Kolb M, Margetts PJ, Anthony DC, Pitossi F, Gauldie J: Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis. J Clin Invest 107:1529-1536, 2001. (Pubitemid 32574639)
24. Choo-Wing R, Nedrelow JH, Homer RJ, Elias JA, Bhandari V: Developmental differences in the responses of IL-6 and IL-13 transgenic mice exposed to hyperoxia. Am J Physiol Lung Cell Mol Physiol 293:L142YL150, 2007. (Pubitemid 47080722)
25. Looney MR, Esmon CT, Matthay M: The role of coagulation pathways and treatment with activated protein C in hyperoxic lung injury. Thorax 64: 114-120, 2009.
26. Waerhaug K, Kuzkov VV, Kuklin VN, Mortensen R, Nordhus KC, Kirov MY, Bjertnaes LJ: Inhaled aerosolised recombinant human activated protein C ameliorates endotoxin-induced lung injury in anaesthetised sheep. Crit Care 13:R51, 2009.
27. Waerhaug K, Kirov MY, Kuzkov VV, Kuklin VN, Bjertnaes LJ: Recombinant human activated protein C ameliorates oleic acid-induced lung injury in awake sheep. Crit Care 12:R146, 2008.
28. Abraham E: Neutrophils and acute lung injury. Crit Care Med 31:S195YS199, 2003. (Pubitemid 36458167)
29. Auten RL, Whorton MH, Mason SN: Blocking neutrophil influx reduces DNA damage in hyperoxia-exposed newborn rat lung. Am J Respir Cell Mol Biol 26: 391-397, 2002.
30. Auten RL, Mason SN, Tanaka DT, Welty-Wolf K, Whorton MH: Anti-neutrophil chemokine preserves alveolar development in hyperoxia-exposed newborn rats. Am J Physiol Lung Cell Mol Physiol 281:L336YL344, 2001. (Pubitemid 32756045)
31. Solá E, Vayá A, Villa P, España F, Estellés A, Garć?a K, Hernández-Mijares A: Obesity and activated protein C resistance. Pathophysiol Haemost Thromb 36: 64-68, 2008.